rosiglitazone has been researched along with Hemorrhage in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbasi, F; Basina, M; Cataldo, NA; Fechner, PY; Giudice, LC; McLaughlin, TL; Reaven, GM | 1 |
1 trial(s) available for rosiglitazone and Hemorrhage
Article | Year |
---|---|
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Topics: Blood Glucose; Female; Hemorrhage; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Menstruation; Ovary; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Vagina | 2006 |